论文部分内容阅读
我院从1994年1月至1999年1月分别用奥曲肽(Octreotide)与垂体后叶素治疗肝硬化合并上消化道大出血86例,现对其临床疗效对比分析如下。1 临床资料 男54例,女32例;年龄19～81岁。其中肝炎后肝硬化74例,血吸虫性肝硬化9例,酒精性肝硬化3例。随机分治疗组41例应用奥曲肽;对照组45例应用垂体后叶素。两组在性别、年龄、肝功能状态、门静脉宽度(B超)及出血量的多少,均无显著性差异。
In our hospital from January 1994 to January 1999 were octreotide (Octreotide) and pituitrin for the treatment of cirrhosis with upper gastrointestinal bleeding in 86 cases, the clinical efficacy of its comparative analysis are as follows. 1 clinical data 54 males and 32 females; aged 19 to 81 years. Among them, 74 cases were liver cirrhosis, 9 cases were schistosomiasis cirrhosis, 3 cases were alcoholic cirrhosis. Forty-one patients were randomized to receive octreotide; 45 patients in the control group were given pituitrin. There was no significant difference between the two groups in terms of gender, age, liver function status, portal vein width (B-mode) and amount of bleeding.